Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.
Nichols DP, Paynter AC, Heltshe SL, Donaldson SH, Frederick CA, Freedman SD, Gelfond D, Hoffman LR, Kelly A, Narkewicz MR, Pittman JE, Ratjen F, Rosenfeld M, Sagel SD, Schwarzenberg SJ, Singh PK, Solomon GM, Stalvey MS, Clancy JP, Kirby S, Van Dalfsen JM, Kloster MH, Rowe SM; PROMISE Study group. Nichols DP, et al. Am J Respir Crit Care Med. 2022 Mar 1;205(5):529-539. doi: 10.1164/rccm.202108-1986OC. Am J Respir Crit Care Med. 2022. PMID: 34784492 Free PMC article.
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study.
Drysdale M, Choate R, Brunton AE, Tiberi S, Gillespie IA, Lininger N, Shrimpton SB, Metersky M, Lapinel NC, McShane PJ, Richards CJ, Swenson C, Sharma H, Mannino D, Winthrop KL; Bronchiectasis and NTM Research Registry Investigators. Drysdale M, et al. Among authors: richards cj. Pulm Pharmacol Ther. 2023 Dec;83:102260. doi: 10.1016/j.pupt.2023.102260. Epub 2023 Sep 21. Pulm Pharmacol Ther. 2023. PMID: 37741357
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients.
Aksamit TR, Locantore N, Addrizzo-Harris D, Ali J, Barker A, Basavaraj A, Behrman M, Brunton AE, Chalmers S, Choate R, Dean NC, DiMango A, Fraulino D, Johnson MM, Lapinel NC, Maselli DJ, McShane PJ, Metersky ML, Miller BE, Naureckas ET, O'Donnell AE, Olivier KN, Prusinowski E, Restrepo MI, Richards CJ, Rhyne G, Schmid A, Solomon GM, Tal-Singer R, Thomashow B, Tino G, Tsui K, Varghese SA, Warren HE, Winthrop K, Zha BS. Aksamit TR, et al. Among authors: richards cj. Am J Respir Crit Care Med. 2024 Jul 1;210(1):108-118. doi: 10.1164/rccm.202307-1165OC. Am J Respir Crit Care Med. 2024. PMID: 38668710
Nebulized hypertonic saline and positive expiratory pressure device use in patients with bronchiectasis: Analysis from the United States Bronchiectasis and NTM research registry.
Basavaraj A, Brunton AE, Choate R, Barker A, Jakharia K, Richards C, Swenson C, Aksamit TR, Metersky ML; Bronchiectasis and NTM research registry investigators.. Basavaraj A, et al. Respir Med Res. 2024 Apr 24;86:101107. doi: 10.1016/j.resmer.2024.101107. Online ahead of print. Respir Med Res. 2024. PMID: 38843603
Nontuberculous Mycobacteria in Cystic Fibrosis.
Richards CJ, Olivier KN. Richards CJ, et al. Semin Respir Crit Care Med. 2019 Dec;40(6):737-750. doi: 10.1055/s-0039-1693706. Epub 2019 Oct 28. Semin Respir Crit Care Med. 2019. PMID: 31659731 Review.
Alcohol and opiate misuse in adults with cystic fibrosis.
Richards CJ, Friedman D, Pinsky H, Gootkind E, Lee H, Yonker L, Georgiopoulos AM. Richards CJ, et al. Pediatr Pulmonol. 2023 Sep;58(9):2535-2542. doi: 10.1002/ppul.26541. Epub 2023 Jun 9. Pediatr Pulmonol. 2023. PMID: 37294071
Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis.
Vieira J, Jesudasen S, Bringhurst L, Sui HY, McIver L, Whiteson K, Hanselmann K, O'Toole GA, Richards CJ, Sicilian L, Neuringer I, Lai PS. Vieira J, et al. Among authors: richards cj. mSystems. 2022 Oct 26;7(5):e0036422. doi: 10.1128/msystems.00364-22. Epub 2022 Aug 24. mSystems. 2022. PMID: 36000724 Free PMC article.
186 results